Introduction {#section5-1753465816657478}
============

First reported by Hamman in [@bibr24-1753465816657478], spontaneous pneumomediastinum (SPM) refers to the presence of extraluminal air in the mediastinum when chest trauma, oesophageal rupture, hollow viscus rupture, barotrauma, underlying lung disease, and other disorders have been excluded \[[@bibr24-1753465816657478]; [@bibr12-1753465816657478]\]. SPM is an uncommon disorder with an incidence of 0.0025% among emergency room visits \[[@bibr32-1753465816657478]; [@bibr21-1753465816657478]\]. SPM is rare in paediatric patients; however, occasional cases are reported to result from forced Valsalva's manoeuvre due to cough, emesis, a first attack of wheeze, or asthma exacerbations \[[@bibr5-1753465816657478]\]. The first paediatric series was reported by Thaler and colleagues in 1964 \[[@bibr42-1753465816657478]\]. In spite of being rare, SPM is probably under-diagnosed in children. Two incidence peaks have been reported; one of them in children under 7 years of age, probably due to lower airways infections, and the other in adolescents, due to asthmatic exacerbations and high airways infections \[[@bibr29-1753465816657478]; [@bibr37-1753465816657478]\].

Several studies have found a number of triggering factors for SPM \[[@bibr9-1753465816657478]; [@bibr29-1753465816657478]; [@bibr31-1753465816657478]\]. As shown by Lee and colleagues, the most common ones are: lower airways infection (43.2%), asthma (21%), oesophageal rupture (5.4%), foreign body aspiration (2.7%), and diabetic ketoacidosis (2.7%), with a cause not being found in about 35.1% of patients (idiopathic SPM) \[[@bibr29-1753465816657478]\]. In recent literature, some cases have been reported due to repeated scuba diving \[[@bibr15-1753465816657478]\], spontaneous bronchial rupture \[[@bibr31-1753465816657478]\], high-frequency oscillatory ventilation \[[@bibr26-1753465816657478]\], influenza A (H1N1) virus infection \[[@bibr35-1753465816657478]; [@bibr36-1753465816657478]\], drug rash with eosinophilia and systemic symptoms (DRESS) syndrome \[[@bibr23-1753465816657478]\], hyperventilation due to anxiety states \[[@bibr12-1753465816657478]\], and inhaled drugs such as cocaine, cannabis, or ecstasy \[[@bibr12-1753465816657478]\].

As a clinical syndrome, pneumomediastinum was first reported in 1819 by Laennec, and its pathophysiology was described in [@bibr30-1753465816657478] by Macklin \[[@bibr30-1753465816657478]\]. A sudden increase in intra-alveolar pressure can cause alveolar rupture and a leak of air resulting in interstitial emphysema. Air may then reach the hilium and cause pneumomediastinum/pneumothorax, or may reach the lung periphery resulting in subpleural bullae (ruptured bullae may also cause pneumothorax). If leaked air spreads into subcutaneous tissues in chest wall and neck, through fascial planes, subcutaneous emphysema occurs. Extension into the rachis resulting in pneumorrhachis is rare but has also been reported in SPM \[[@bibr16-1753465816657478]; [@bibr22-1753465816657478]; [@bibr33-1753465816657478]\].

Clinical presentation includes the following triad: acute substernal chest pain (90%), subcutaneous emphysema (90%), and variably severe dyspnoea (30%) \[[@bibr12-1753465816657478]\]. Other reported symptoms are neck pain (20%) and low-to-moderate pain on swallowing (20%), whereas torticollis, dorsally-radiating pain, dysphonia, loss of lung dullness, and paradoxical pulse are very rare. Cyanosis, haemodynamic compromise, and even an associated pneumopericardium have been reported in most severe cases \[[@bibr27-1753465816657478]\].

Subcutaneous emphysema refers to air being present within subcutaneous tissue. Massive build-up of air can even be life-threatening due to chest compression, resulting in progressive hypoxemia and hypercapnia. Substernal crackles synchronous with heart systole (Hamman's sign) are common (40--80%) \[[@bibr15-1753465816657478]\]. Differential diagnoses include pneumomediastinum (though association is common), oesophageal perforation (Boerhaave syndrome if spontaneously developed), pneumothorax, hollow viscus rupture, chest trauma, foreign body aspiration, and acute coronary syndrome and pulmonary thromboembolism, both very rare findings in paediatric patients \[[@bibr9-1753465816657478]; [@bibr15-1753465816657478]; [@bibr37-1753465816657478]\]. In clinical practice, diagnosis should be confirmed by chest X-ray, including a lateral view to show extraluminal air \[[@bibr15-1753465816657478]\]. When the diagnosis is uncertain, chest computerized tomography (CT) allows small amounts of air in the mediastinum and tracheal injuries to be detected \[[@bibr15-1753465816657478]; [@bibr11-1753465816657478]\]. If an oesophageal rupture is suspected, an oesophagogram should be obtained \[[@bibr12-1753465816657478]; [@bibr9-1753465816657478]\].

SPM is usually benign and self-limiting, with only supporting therapy being needed; rest for 1--4 days, analgesia, oxygen, and clinical monitoring \[[@bibr12-1753465816657478]; [@bibr15-1753465816657478]; [@bibr11-1753465816657478]\]. Underlying disorders should be treated, if possible \[[@bibr9-1753465816657478]\]. SPM usually resolves spontaneously within 2--7 days \[[@bibr15-1753465816657478]\]. Severe cases, such as tension pneumomediastinum or tension pneumothorax may require invasive measures (e.g. subcutaneous drains) \[[@bibr9-1753465816657478]\].

Asthma exacerbations have classically been described as a cause of SPM \[[@bibr25-1753465816657478]\]. An increased airway pressure due to a chronic inflammatory disorder appears to reduce airway lumen. In children, SPM can appear with the first asthma exacerbation or can appear later as a complication of asthma \[[@bibr43-1753465816657478]; [@bibr5-1753465816657478]\]. However, reported frequency of SPM in asthmatic patients is low \[[@bibr29-1753465816657478]\]. In a series of 12,000 asthmatic children seen at a paediatric emergency department, SPM was observed in only 0.3% of patients \[[@bibr41-1753465816657478]\]. In a series of 479 patients aged 1--20 years hospitalized with asthma, SPM incidence was 5% \[[@bibr17-1753465816657478]\]. Follow up of patients with SPM has shown subclinical or clinical asthma in some cases \[[@bibr14-1753465816657478]\], and asthma has been reported in 50% of SPM patients in a Taiwan series \[[@bibr8-1753465816657478]\].

Recently, a large systematic review of 600 patients with SPM, mostly young adults, was published \[[@bibr13-1753465816657478]\]. Previous asthma was found in 13.7%; however, no specific data on asthmatic or paediatric patients were provided. Furthermore, very recently, a large series of SPM in paediatric patients has also been reported \[[@bibr21-1753465816657478]\]. In this retrospective review, 96 children with 99 episodes were identified and their characteristics and management were described; 38.4% were asthmatic. This will be a landmark study in the field and includes some specific data on management and outcomes in asthmatic children as a group, although no specific description of such patients is reported. Taking into account that detailed descriptions of SPM in asthmatic children are scarce, we aimed at improving current understanding of their features and outcomes regarding both SPM and underlying asthma, by means of a systematic review and a report of a typical case.

Case report {#section6-1753465816657478}
===========

A 10-year-old asthmatic girl attended the emergency department with a persistent dry cough, dyspnoea and severe chest/neck pain, after having been exposed to environmental smoke and ash after a recent fire. Family history: father with asthma associated with sensitization to house dust mites (HDM); two brothers (aged 17 and 13) with allergic asthma associated with sensitization to HDM, olive, and *Parietaria* pollen, respectively. Personal history: preterm birth (36 weeks) and small for dates (2175 g). Hyperreactive airways after bronchiolitis at age 9.

Clinical examination: no fever, 40 breaths/min, 135 beats/min, sat O~2~ 97%, blood pressure 105/50 mmHg, sallow skin, bags under the eyes, and normal peripheral perfusion. Chest: inspiratory substernal retraction; reduced vesicular breath sound and widespread persistent inspiratory/expiratory wheezing in left hemithorax. Centrally-located trachea, and heart sounds neither distant nor shifted. Palpable subcutaneous emphysema resulting in crepitus over lateral left neck area, left supraclavicular pit and first ipsilateral rib. Asthma attack was classified as severe based on a Wood--Downes--Ferres scoring of 8 \[[@bibr46-1753465816657478]; [@bibr19-1753465816657478]\]. Laboratory tests: arterial blood gases: pH 7.33, pCO~2~ 51.6 mmHg, pO~2~ 18.1 mmHg, HCO~3~ 27 mmol/l, base excess + 0.6 mmol/l. Biochemistry: C reactive protein 20.2 mg/l; normal renal function tests and electrolyte levels. Haematology: haemoglobin 14.7 g/dl; white blood cell count 12.7 × 10^9^/l; neutrophil count 77.3%; platelet count 303 × 10^9^/l. Imaging: chest X-ray showed pneumomediastinum with subcutaneous emphysema in supraclavicular and left neck area with no pneumothorax ([Figure 1](#fig1-1753465816657478){ref-type="fig"}).

![Pneumomediastinum (red arrow) with subcutaneous emphysema in supraclavicular and left neck regions (yellow arrows).](10.1177_1753465816657478-fig1){#fig1-1753465816657478}

The patient was admitted and received noninvasive monitoring, analgesia, oxygen (5 l/min), inhaled bronchodilators (salbutamol and ipratropium), intravenous steroids, and omeprazole as a prophylaxis for ulcus. After 72 hours, a chest X-ray showed a substantially reduced amount of gas in the neck and mediastinum. The patient was discharged at day 4; prescribed therapy at discharge included budesonide 200 µg twice daily with AeroChamber, and she was advised not to perform extreme physical activity to avoid pneumothorax development due to potential bullae.

Prick tests for usual inhalants were performed. Based on European Academy of Allergy and Clinical Immunology recommendations, a positive test was defined as a 3 mm diameter papule 15 minutes after the test \[[@bibr18-1753465816657478]; [@bibr4-1753465816657478]\]. Prick tests were positive for HDM: *Dermatophagoides pteronyssinus (+++++), Dermatophagoides farinae (++++)*, and for dog (++) and cat epithelia (++).

Pulmonary function tests: forced vital capacity (FVC) 3.47 (104%), forced expiratory volume in 1 second (FEV~1~): 3.12 (105%), FEV~1~/FVC: 102%, forced expiratory flow (FEF 25--75%): of 99% of predicted by age, improving to 115% after bronchodilator administration peak expiratory flow. Bronchodilator test was positive and fractional exhaled nitric oxide (FeNo) using Mini Wright was 37.1 ppb NO (normal \< 30 NO). A nonenhanced chest CT excluded bullae ([Figure 2](#fig2-1753465816657478){ref-type="fig"}).

![Chest computerized tomography: no subpleural bullae are observed.](10.1177_1753465816657478-fig2){#fig2-1753465816657478}

Clinical course: A diagnosis of severe persistent allergic asthma (allergy to HDM) was established. Asthma control was not adequate with an inhaled corticosteroid and long-acting beta2 agonist. Sublingual immunotherapy (SLIT) with STALORAL^®^ 300 IR, containing a mix of HDM, was added, which proved highly efficient, with eventual control of asthma symptoms.

Literature review method {#section7-1753465816657478}
========================

A systematic review was carried out in PubMed to identify reported cases of SPM in asthmatic children. Search terms were 'spontaneous pneumomediastinum' and 'asthma'. Only English-language articles published after 1 Jan 1995 were included. The search string was: (spontaneous\[All Fields\] AND ('mediastinal emphysema'\[MeSH Terms\] OR ('mediastinal'\[All Fields\] AND 'emphysema'\[All Fields\]) OR 'mediastinal emphysema'\[All Fields\] OR 'pneumomediastinum'\[All Fields\])) AND ('asthma'\[MeSH Terms\] OR 'asthma'\[All Fields\]) AND English\[lang\] AND ('1995/01/01'\[PDAT\]: '3000/12/31'\[PDAT\]). Full articles were retrieved for those references that included asthmatic patients \<18 years of age based on a review of titles and abstracts. A manual search for additional references in selected articles (snowball method) was also performed. Articles providing a description of one or several asthmatic patients \<18 years of age with SPM were selected. Data from reported cases were abstracted and tabulated.

Results {#section8-1753465816657478}
=======

Overall, 63 references were identified. A total of 35 were selected for full article retrieval and of these, 17 articles complying with the inclusion criteria were found. A total of 114 cases were identified and tabulated ([Table 1](#table1-1753465816657478){ref-type="table"}). Cases had been reported from Europe, Asia, and the Americas. The age range was 1--18 years, but most patients were teenagers, with a similar number of cases having been reported in boys and girls.

###### 

Reported cases of SPM in asthmatic children.

![](10.1177_1753465816657478-table1)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                        Year   Country          *N*   Mean age\                Sex     Presentation                                                                  Diagnostic imaging                                                Complications                       Therapy                                                Course                                  Length of hospital stay (days)
                                                                 (or individual age)                                                                                                                                                                                                                                                                                                 
  -------------------------------- ------ ---------------- ----- ------------------------ ------- ----------------------------------------------------------------------------- ----------------------------------------------------------------- ----------------------------------- ------------------------------------------------------ --------------------------------------- --------------------------------------------------
  \[[@bibr21-1753465816657478]\]   2015   USA              38    10.3                     --      --                                                                            --                                                                --                                  --                                                     resolution\                             no difference from nonasthmatics
                                                                                                                                                                                                                                                                                                                                             recurrent pneumomediastinum (*n* = 3)   

  \[[@bibr20-1753465816657478]\]   2014   Turkey           1     12                       M       chronic coughing                                                              CT                                                                no                                  inhaled steroids, analgesics                           resolution                              a few days

  \[[@bibr22-1753465816657478]\]   2014   France           1     18                       F       acute swelling of the face, neck, and upper chest                             CT                                                                pneumorrhachis                      rest, bronchodilators, corticosteroids                 resolution                              7

  \[[@bibr45-1753465816657478]\]   2013   Taiwan           15    *n* = 2 under 6 years\   --      acute exacerbation                                                            chest X-ray\                                                      no                                  --                                                     resolution                              5.8 (over 6 years)\
                                                                 *n* = 13 over 6 years                                                                                          (sensitivity, 89.1%)\                                                                                                                                                                                11.4 (under 6 years)
                                                                                                                                                                                lateral neck radiographs                                                                                                                                                                             

  \[[@bibr34-1753465816657478]\]   2012   Japan            2     15--17                   --      neck and chest pain, dyspnoea and discomfort in the chest                     chest and neck X-rays                                             no                                  --                                                     resolution                              4 or 5

  \[[@bibr29-1753465816657478]\]   2010   Taiwan           4     15.8                     2 M\    --                                                                            --                                                                associated pneumothorax (*n* = 3)   analgesics, rest, oxygen therapy                       resolution                              4.2
                                                                                          2 F                                                                                                                                                                                                                                                                                        

  \[[@bibr38-1753465816657478]\]   2010   Venezuela        1     17                       F       severe asthma exacerbation                                                    chest X-rays                                                      no                                  oxygen therapy, parenteral steroids, bronchodilators   resolution                              2

  \[[@bibr7-1753465816657478]\]    2009   Taiwan           6     --                                                                                                             chest X-rays                                                      --                                  --                                                     resolution                              4.8 (significantly longer than in nonasthmatics)

  \[[@bibr28-1753465816657478]\]   2009   Taiwan           2     \<10                     2 F     wheezing, first attack of asthma                                                                                                                no                                  bronchodilators                                        resolution                              --

  \[[@bibr5-1753465816657478]\]    2007   USA              1     4                        F       first-time wheezing                                                           chest X-ray (spinnaker sail sign and continuous diaphragm sign)   no                                  supportive care                                        resolution                              --

  \[[@bibr16-1753465816657478]\]   2006   India            1     18                       M       swelling over the neck and upper chest after a mild episode of bronchospasm   CT                                                                pneumorrhachis                                                                             resolution                              --

  \[[@bibr1-1753465816657478]\]    2006   United Kingdom   1     1                        M       cough, dyspnoea, first attack of asthma                                       chest X-ray                                                       no                                  salbutamol,\                                           resolution                              7
                                                                                                                                                                                                                                                                                      steroids, antibiotics, oxygen therapy                                                          

  \[[@bibr8-1753465816657478]\]    2005   Taiwan           8     9.6                              asthma exacerbations                                                          chest X-rays                                                      --                                  --                                                     resolution                              3.3

  \[[@bibr27-1753465816657478]\]   2001   Turkey           1     4                        F       dyspnoea, chest pain, palpitation and cough                                   chest X-rays                                                      no                                  salbutamol, budesonide,\                               resolution                              10
                                                                                                                                                                                                                                                                                      oxygen therapy                                                                                 

  \[[@bibr3-1753465816657478]\]    1999   Austria          1     18                       M       severe respiratory compromise                                                 chest X-rays                                                      no                                  medical treatment\                                     resolution                              12
                                                                                                                                                                                                                                                                                      for status asthmaticus                                                                         

  \[[@bibr6-1753465816657478]\]    1997   Italy            1     13                       M       coughing during an asthmatic attack                                           CT                                                                fever                               steroids, bronchodilators,\                            resolution                              8
                                                                                                                                                                                                                                                                                      antibiotics                                                                                    

  \[[@bibr41-1753465816657478]\]   1996   USA              30    11.8                     16 M\   chest pain was reported in 27%\                                               X-rays                                                            no                                  --                                                     small increase of SPM (*n* =3)\         --
                                                                                          14 F    subcutaneous emphysema was detected in 73%                                                                                                                                                                                                 resolution                              
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CT, computerized tomography; F, female; M, male; SPM, spontaneous pneumomediastinum.

Clinical presentation was associated with an asthma exacerbation in a number of cases. However, in four patients, SPM was a sign of their first asthma exacerbation or first time wheezing. Other presenting features were chest pain, dyspnoea, cough, and particularly acute swelling of the face, neck, and upper chest. Subcutaneous emphysema was present in most patients.

Diagnosis was most commonly achieved by means of chest X-ray in older reports (sensitivity 89.1% in a reported series) and CT in most recent ones. Lateral neck radiographs appear to be very useful in doubtful cases. Most patients had no complications, although three cases of pneumothorax and two cases of pneumorrhachis were reported.

Therapy was mainly based on supportive care, rest, oxygen therapy, analgesics, steroids, and bronchodilators. All patients recovered spontaneously, in spite of a small initial increase in SPM in a few cases. However, in the largest reported series, three cases of recurrent SPM were found during a prolonged follow up. All patients were discharged after 2--12 days, and a series comparing asthmatic *versus* nonasthmatic SPM patients showed no difference in length of stay.

Discussion {#section9-1753465816657478}
==========

SPM is an uncommon disease that usually has a benign course. It should be treated conservatively unless a complication requires using invasive procedures. Although few cases of SPM have been fully described in asthmatic children, our review confirms that asthma, and asthma exacerbation, appears to be one of the most prominent risk factors for SPM ([Table 1](#table1-1753465816657478){ref-type="table"}). SPM has been reported both as a consequence of an asthma exacerbation and as a sign of a first asthma attack in children. SPM may be associated with poorly-controlled asthma. A majority of cases appear to occur in teenagers and no obvious differences in incidence have been reported between the sexes. Chest X-ray is increasingly being replaced by CT to confirm diagnosis, whereas pneumomediastinum has recently been reported as a sonographic mimic of pneumothorax \[[@bibr39-1753465816657478]\]. Clinical course in reported cases has been generally favourable with spontaneous recovery being achieved after hospital admission and supportive care. Very recently, unusual cases of SPM have also been reported in nonasthmatic children with exercise-induced bronchoconstriction \[[@bibr2-1753465816657478]\], a syndrome causing transient narrowing of lower airway either in the presence or the absence of clinical asthma \[[@bibr44-1753465816657478]\].

The usual course of SPM is spontaneous resolution after a few days, if supporting therapy is provided to the patient and good asthma control is achieved. Recurrent SPM may occur in asthmatic children, thus, from our point of view, careful control of asthma appears to be particularly important in such patients. Alpha1-antitrypsin deficiency screening has been recently recommended in patients with asthma and was performed in our patient for differential diagnosis purposes \[[@bibr40-1753465816657478]; [@bibr10-1753465816657478]\]. In our patient, SPM and subcutaneous emphysema were associated with severe asthma. Control of asthma symptoms proved particularly difficult to achieve. To our knowledge, this is the first patient reported with asthma-associated SPM that has been treated with SLIT. Our case suggested SLIT could change asthma course in children and may avoid potential complications such as SPM.

In conclusion, it is important to stress the importance of an early identification of patients at risk of SPM, which would avoid the high number of under-diagnosed cases. Moreover, patients should be treated not only with supportive therapy but also with measures to achieve control of the underlying cause of SPM (such as poorly-controlled asthma).

**Funding:** The author(s) received no financial support for the research, authorship, and/or publication of this article.

**Conflict of interest statement:** The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
